JAM
ARCT icon

Jupiter Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Jupiter Asset Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-319,446
Closed -$3.38M – 438
2025
Q1 		$3.38M Hold
319,446
– – 0.03% 316
2024
Q4 		$5.42M Sell
319,446
-32,531
-9% -$612K 0.05% 272
2024
Q3 		$8.17M Sell
351,977
-573
-0.2% -$12.3K 0.07% 241
2024
Q2 		$8.58M Sell
352,550
-9,794
-3% -$297K 0.08% 223
2024
Q1 		$12.2M Hold
362,344
– – 0.12% 203
2023
Q4 		$11.4M Buy
362,344
+167,563
+86% +$3.98M 0.11% 200
2023
Q3 		$4.98M Buy
+194,781
New +$6M 0.06% 248

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jupiter Asset Management's ARCT Position: Q2 2025 in Review

Jupiter Asset Management sold out of Arcturus Therapeutics (ARCT) in Q2 2025, closing a stake of 319,446 shares — an estimated $3.38M sold.

Jupiter Asset Management first reported a position in ARCT in Q3 2023 and held it in 7 quarters. The position peaked at $12.2M in Q1 2024. 143 funds tracked by Wall St. Rank hold ARCT as of Q2 2025.

  • Jupiter Asset Management reported no remaining Arcturus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Jupiter Asset Management sold 319,446 Arcturus Therapeutics shares in Q2 2025, an estimated $3.38M.
  • Jupiter Asset Management first reported a position in Arcturus Therapeutics in Q3 2023 and held it in 7 quarters.
  • Jupiter Asset Management's Arcturus Therapeutics position peaked at $12.2M in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2025.

Based on Jupiter Asset Management's 13F filing for Q2 2025, filed 8 Aug 2025.